{"entity":{"type":"insider","cik":"0001399781","url":"/insider/0001399781","json_url":"/insider/0001399781.json","name":"NewcoGen Elan LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":5,"first":"2007-05-31","last":"2012-08-22","span_basis":"filed_date"},"name_variants":[{"name":"NewcoGen Elan LLC","source":"filing","n_filings":5,"first_seen":"2007-05-31","last_seen":"2012-08-22"}],"transactions":[{"id":3059637,"accession":"0001181431-12-046973","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-12-046973","line_url":"/filing/0001181431-12-046973#line-4","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"NewcoGen Group, Inc.; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; NewcoGen Elan LLC; AFEYAN NOUBAR","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23.0,"shares_display":"23","price_per_share":5.83,"price_display":"5.83","price_state":"stated","total_value":134.09,"total_display":"134.09","shares_owned_after":298137.0,"shares_owned_after_display":"298,137","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-08-20","filed_date":"2012-08-22","scope":"insider"},{"id":3059632,"accession":"0001181431-12-046973","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-12-046973","line_url":"/filing/0001181431-12-046973#line-3","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"NewcoGen Group, Inc.; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; NewcoGen Elan LLC; AFEYAN NOUBAR","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23.0,"shares_display":"23","price_per_share":5.83,"price_display":"5.83","price_state":"stated","total_value":134.09,"total_display":"134.09","shares_owned_after":291738.0,"shares_owned_after_display":"291,738","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-08-20","filed_date":"2012-08-22","scope":"insider"},{"id":3059631,"accession":"0001181431-12-046973","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-046973","line_url":"/filing/0001181431-12-046973#line-2","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"NewcoGen Group, Inc.; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; NewcoGen Elan LLC; AFEYAN NOUBAR","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23.0,"shares_display":"23","price_per_share":5.83,"price_display":"5.83","price_state":"stated","total_value":134.09,"total_display":"134.09","shares_owned_after":285339.0,"shares_owned_after_display":"285,339","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-08-20","filed_date":"2012-08-22","scope":"insider"},{"id":3059626,"accession":"0001181431-12-046973","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-046973","line_url":"/filing/0001181431-12-046973#line-1","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"NewcoGen Group, Inc.; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; NewcoGen Elan LLC; AFEYAN NOUBAR","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13.0,"shares_display":"13","price_per_share":5.83,"price_display":"5.83","price_state":"stated","total_value":75.79,"total_display":"75.79","shares_owned_after":278940.0,"shares_owned_after_display":"278,940","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-08-20","filed_date":"2012-08-22","scope":"insider"},{"id":9160361,"accession":"0001181431-11-009580","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001181431-11-009580","line_url":"/filing/0001181431-11-009580#line-26","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"NewcoGen PE LLC; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; AFEYAN NOUBAR; NEWCOGEN EQUITY INVESTORS LLC; NewcoGen Group, Inc.; ST NewcoGen LLC; NewcoGen Elan LLC; NEWCOGEN GROUP LLC; NewcoGen Long Reign Holding LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":714286.0,"shares_display":"714,286","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":5000002.0,"total_display":"5,000,002.00","shares_owned_after":714286.0,"shares_owned_after_display":"714,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-09","filed_date":"2011-02-11","scope":"insider"},{"id":9160360,"accession":"0001181431-11-009580","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001181431-11-009580","line_url":"/filing/0001181431-11-009580#line-25","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"NewcoGen PE LLC; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; AFEYAN NOUBAR; NEWCOGEN EQUITY INVESTORS LLC; NewcoGen Group, Inc.; ST NewcoGen LLC; NewcoGen Elan LLC; NEWCOGEN GROUP LLC; NewcoGen Long Reign Holding LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":271429.0,"shares_display":"271,429","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":1900003.0,"total_display":"1,900,003.00","shares_owned_after":2351447.0,"shares_owned_after_display":"2,351,447","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-09","filed_date":"2011-02-11","scope":"insider"},{"id":9160359,"accession":"0001181431-11-009580","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001181431-11-009580","line_url":"/filing/0001181431-11-009580#line-24","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"NewcoGen PE LLC; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; AFEYAN NOUBAR; NEWCOGEN EQUITY INVESTORS LLC; NewcoGen Group, Inc.; ST NewcoGen LLC; NewcoGen Elan LLC; NEWCOGEN GROUP LLC; NewcoGen Long Reign Holding LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":42858.0,"shares_display":"42,858","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":300006.0,"total_display":"300,006.00","shares_owned_after":2184800.0,"shares_owned_after_display":"2,184,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-09","filed_date":"2011-02-11","scope":"insider"},{"id":9160358,"accession":"0001181431-11-009580","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001181431-11-009580","line_url":"/filing/0001181431-11-009580#line-23","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"NewcoGen PE LLC; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; AFEYAN NOUBAR; NEWCOGEN EQUITY INVESTORS LLC; NewcoGen Group, Inc.; ST NewcoGen LLC; NewcoGen Elan LLC; NEWCOGEN GROUP LLC; NewcoGen Long Reign Holding LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35715.0,"shares_display":"35,715","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":250005.0,"total_display":"250,005.00","shares_owned_after":526560.0,"shares_owned_after_display":"526,560","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-09","filed_date":"2011-02-11","scope":"insider"},{"id":9160357,"accession":"0001181431-11-009580","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001181431-11-009580","line_url":"/filing/0001181431-11-009580#line-22","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"NewcoGen PE LLC; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; AFEYAN NOUBAR; NEWCOGEN EQUITY INVESTORS LLC; NewcoGen Group, Inc.; ST NewcoGen LLC; NewcoGen Elan LLC; NEWCOGEN GROUP LLC; NewcoGen Long Reign Holding LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21428.0,"shares_display":"21,428","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":149996.0,"total_display":"149,996.00","shares_owned_after":92294.0,"shares_owned_after_display":"92,294","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-09","filed_date":"2011-02-11","scope":"insider"},{"id":9160356,"accession":"0001181431-11-009580","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001181431-11-009580","line_url":"/filing/0001181431-11-009580#line-21","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"NewcoGen PE LLC; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; AFEYAN NOUBAR; NEWCOGEN EQUITY INVESTORS LLC; NewcoGen Group, Inc.; ST NewcoGen LLC; NewcoGen Elan LLC; NEWCOGEN GROUP LLC; NewcoGen Long Reign Holding LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21428.0,"shares_display":"21,428","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":149996.0,"total_display":"149,996.00","shares_owned_after":92126.0,"shares_owned_after_display":"92,126","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-09","filed_date":"2011-02-11","scope":"insider"},{"id":9160355,"accession":"0001181431-11-009580","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001181431-11-009580","line_url":"/filing/0001181431-11-009580#line-20","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"NewcoGen PE LLC; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; AFEYAN NOUBAR; NEWCOGEN EQUITY INVESTORS LLC; NewcoGen Group, Inc.; ST NewcoGen LLC; NewcoGen Elan LLC; NEWCOGEN GROUP LLC; NewcoGen Long Reign Holding LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14285.0,"shares_display":"14,285","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":99995.0,"total_display":"99,995.00","shares_owned_after":140013.0,"shares_owned_after_display":"140,013","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-09","filed_date":"2011-02-11","scope":"insider"},{"id":9160354,"accession":"0001181431-11-009580","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001181431-11-009580","line_url":"/filing/0001181431-11-009580#line-19","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"NewcoGen PE LLC; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; AFEYAN NOUBAR; NEWCOGEN EQUITY INVESTORS LLC; NewcoGen Group, Inc.; ST NewcoGen LLC; NewcoGen Elan LLC; NEWCOGEN GROUP LLC; NewcoGen Long Reign Holding LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10714.0,"shares_display":"10,714","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":74998.0,"total_display":"74,998.00","shares_owned_after":298061.0,"shares_owned_after_display":"298,061","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-09","filed_date":"2011-02-11","scope":"insider"},{"id":9160353,"accession":"0001181431-11-009580","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001181431-11-009580","line_url":"/filing/0001181431-11-009580#line-18","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"NewcoGen PE LLC; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; AFEYAN NOUBAR; NEWCOGEN EQUITY INVESTORS LLC; NewcoGen Group, Inc.; ST NewcoGen LLC; NewcoGen Elan LLC; NEWCOGEN GROUP LLC; NewcoGen Long Reign Holding LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10714.0,"shares_display":"10,714","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":74998.0,"total_display":"74,998.00","shares_owned_after":276600.0,"shares_owned_after_display":"276,600","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-09","filed_date":"2011-02-11","scope":"insider"},{"id":5649001,"accession":"0001179110-09-013533","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-09-013533","line_url":"/filing/0001179110-09-013533#line-1","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"ST NewcoGen LLC; NEWCOGEN EQUITY INVESTORS LLC; NEWCOGEN GROUP LLC; Flagship Ventures General Partner LLC; NewcoGen PE LLC; KANIA EDWIN M JR; NewcoGen Elan LLC; NewcoGen Group, Inc.; Flagship Ventures Fund 2004 L P; Flagship Ventures Management, Inc.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":242931.0,"shares_display":"242,931","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":12192640.0,"shares_owned_after_display":"12,192,640","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-18","filed_date":"2009-09-22","scope":"insider"},{"id":3406922,"accession":"0001179110-08-021552","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-08-021552","line_url":"/filing/0001179110-08-021552#line-1","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"NewcoGen PE LLC; NewcoGen Group, Inc.; KANIA EDWIN M JR; NewcoGen Elan LLC; ST NewcoGen LLC; NEWCOGEN GROUP LLC; AFEYAN NOUBAR; NEWCOGEN EQUITY INVESTORS LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8620690.0,"shares_display":"8,620,690","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":11949709.0,"shares_owned_after_display":"11,949,709","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-23","filed_date":"2008-12-29","scope":"insider"},{"id":7559583,"accession":"0001179110-07-011724","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-07-011724","line_url":"/filing/0001179110-07-011724#line-2","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"AFEYAN NOUBAR; NewcoGen PE LLC; KANIA EDWIN M JR; NEWCOGEN GROUP LLC; ST NewcoGen LLC; NewcoGen Elan LLC; NEWCOGEN EQUITY INVESTORS LLC; NewcoGen Group, Inc.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":222222.0,"shares_display":"222,222","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":1999998.0,"total_display":"1,999,998.00","shares_owned_after":3329019.0,"shares_owned_after_display":"3,329,019","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-05-30","filed_date":"2007-05-31","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001407038","name":"BG Medicine, Inc.","url":"/issuer/0001407038","role":"Ten percent owner","n_filings":2,"first_seen":"2011-02-11","last_seen":"2012-08-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001274563","name":"HELICOS BIOSCIENCES CORP","url":"/issuer/0001274563","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2007-05-31","last_seen":"2009-09-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001399781","retrieved_at":"2026-08-20T21:08:56+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}